原发性皮肤黑色素瘤组织学消退的预后作用:系统评价与荟萃分析
The prognostic significance of histological regression in primary melanoma has been debated for many years. We aim to review the evidence to see how histological regression may affect prognosis.…
要点
- 漏斗图未提示发表偏倚。
核心结论
- 组织学消退是原发性皮肤黑色素瘤患者生存的保护因素。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、Scopus和Cochrane Library(1966年1月1日至2015年8月1日)。
- 采用随机效应模型汇总结局指标,异质性用χ2检验和I2统计量评估。
主要发现
- 漏斗图未提供发表偏倚证据。
临床怎么用
- 评估原发性黑色素瘤预后时可将组织学消退作为有利预后指标参考。
局限性
- 检索截止2015年8月1日,未纳入此后发表的研究。
- 仅基于汇总数据,无法排除各研究间方法学差异的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prognostic significance of histological regression in primary melanoma has been debated for many years. We aim to review the evidence to see how histological regression may affect prognosis. A systematic review was performed by searching in MEDLINE, Scopus and the Cochrane Library from 1 January 1966 to 1 August 2015. All studies reporting hazard ratios or data on survival and histological regression were included. Primary random-effects meta-analyses were used to summarize outcome measures. Heterogeneity was assessed using the χ2 -test and I2 -statistic. To assess the potential bias of small studies we used funnel plots and the Begg and Mazumdar adjusted rank correlation method. Summaries of survival outcomes were measured as hazard ratios or relative risk of death at 5 years according to the presence of histological regression of primary melanoma. In total, 183 articles were reviewed out of 1876 retrieved. Ten studies comprising 8557 patients were included. Patients with histological regression had a lower relative risk of death (0·77, 95% confidence interval 0·61-0·97) than those without. Examination of the funnel plot did not provide evidence of publication bias. The results showed that histological regression is a protective factor for survival.
引用
- Gualano MR, Osella-Abate S, Scaioli G, et al. Prognostic role of histological regression in primary cutaneous melanoma: a systematic review and meta-analysis. Br J Dermatol. 2017. PMID: 28386936. doi:10.1111/bjd.15552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。